Anogenital distance (AGD), the length from the anus to specific genital landmarks, is a well validated, testosterone sensitive, sexually dimorphic biomarker used in many kinds of medical and evolutionary research in diverse species of mammals, including humans. Current research into the effects of testosterone on women’s reproductive health and disease is motivating increased interest in measuring female AGD. Studies quantifying female AGD typically employ a clinician, such as a gynecologist or nurse, to conduct the measurements. This methodology maximizes accuracy but imposes notable limitations on data collection. All participants submitted self-measurements online and completed a small set of questionnaires, including tests assessing spatial cognition. The accuracy of AGD self-measurements, based on agreement between self- and clinic-measurements, was moderate. Measurement accuracy was predicted by performance on the mental rotation test, such that women who performed better on this test demonstrated greater accuracy in measuring the anus to posterior fourchette distance. We describe ideas for improving the accuracy of the self-measurement technique. Self-measurement of AGD would increase the number and diversity of women represented in studies of reproductive health, reduce research expenses, and expedite research into the effects of prenatal testosterone and endocrine disruption on female health and disease.

The authors have declared no competing interest.

NSERC Discovery Grant 2019-04208

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the Simon Fraser University Research Ethics Board Study Number 30001642.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data will be made available upon reasonable request